Connect with us

Hi, what are you looking for?

Economy

Thai hospital banned from offer to sell COVID-19 vaccine

BANGKOK — A private Thai hospital was ordered on Sunday to stop advertising COVID-19 vaccinations for sale in advance on the grounds that no vaccine is yet approved in Thailand.

Vibhavadi Hospital told Reuters its online offer for 1,000 initial reservations for the two-dose Moderna vaccine had been the result of a misunderstanding. With reservations priced at 4,000 baht, the total cost of getting vaccinated would have been 10,000 baht ($330).

As the first governments begin vaccine rollouts around the world, questions have been raised over how the limited supplies are prioritised and whether people will be able to pay to jump the queue.

The Ministry of Health said in a statement that no COVID-19 vaccine had been approved for use in Thailand yet and that advertising one violated hospital regulations.

“The removal of the advertisement was ordered,” it said.

Chaisit Kupwiwat, a director at Vibhavadi Hospital, told Reuters: “There was a misunderstanding and so we’ve stopped the programme… We planned to order the vaccines, but now we’ve stopped.”

The hospital had sought reservations by Jan. 31 for vaccinations later in 2021.

Moderna did not respond immediately to an emailed request for comment on any such sale.

Thailand has signed an advance deal for AstraZeneca’s potential COVID-19 vaccine, but has not set rollout plans for any vaccine yet.

Moderna’s vaccine this month became the second to get emergency use authorisation from the U.S. Food and Drug Administration after the Pfizer and BioNTech vaccine.

Moderna has said it will deliver approximately 20 million doses to the U.S. government this year and is expected to have between 100 million and 125 million delivered globally in the first quarter of 2021.

In August, Moderna said it was pricing its vaccine at $32 to $37 per dose for smaller deals.

Thailand is a major hub for medical tourism, drawing patients from Asia, the Middle East and beyond. — Reuters

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Get the daily email that makes reading the news actually enjoyable. Stay informed and entertained, for free.
Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

Latest

Economy

Finding a property to settle in after years of being in the pandemic may leave home seekers and smart investors wary of whether their...

Economy

  Spotlight is BusinessWorld’s sponsored section that allows advertisers to amplify their brand and connect with BusinessWorld’s audience by enabling them to publish their...

Economy

As part of its development agenda for Pakil in Laguna, Ahunan Power Inc. (Ahunan) launched a corporate social responsibility (CSR) program dubbed “Tayo Na...

Economy

By Kyle Aristophere T. Atienza and Revin Mikhael D. Ochave, Reporters AN INVESTIGATION is underway over the “illegal” sugar importation order that was aimed...

Economy

By Diego Gabriel C. Robles THE PHILIPPINES now aims to become a high-income economy by 2045 at the latest, Socioeconomic Planning Secretary Arsenio M....

Economy

THE SY SIBLINGS remained the richest in the Philippines, despite a $4-billion drop in their net worth in 2022, according to Forbes Asia. The...

You May Also Like

Investing

Having a good Instagram marketing agency to back up your Instagram account is an absolute must going into the new year. With competition stronger...

Economy

Ivermectin, an existing drug against parasites including head lice, has had a checkered history when it comes to treating COVID-19. The bulk of studies...

Investing

Insomnia is the most common sleep disorder in the global population. Therefore, it is a problem that many people suffer or have suffered throughout...

Investing

Instagram still holds the top spot for social media in terms of building brand reputation and expanding business potential. Every day, more and more...

Disclaimer: SmartRetirementReport.com, its managers, its employees, and assigns (collectively "The Company") do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2021 SmartRetirementReport. All Rights Reserved.